SCHEMBL26415667

SCHEMBL26415667

c1ccc(-c2nc3ccccc3nc2-c2ccc(-c3cccc4oc5cc(-c6ccc7ccc(N(c8ccccc8)c8ccccc8)cc7c6)ccc5c34)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB5 P28074 1/20 0.34
L3MBTL1 Q9Y468 4/20 0.33
LMNA P02545 4/20 0.33
KDM4E B2RXH2 3/20 0.33
GAA P10253 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
MTOR P42345 1/20 0.32
PIK3CG P48736 1/20 0.32
HCRTR1 O43613 2/20 0.32
ALDH1A1 P00352 4/20 0.32
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
THRB P10828 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26415659 0.93 L3MBTL1 (0.36) PSMB5L3MBTL1LMNAKDM4EGAA
SCHEMBL26415666 0.89 L3MBTL1 (0.33) L3MBTL1LMNAKDM4EGAATDP1
SCHEMBL26416716 0.89 L3MBTL1 (0.38) PSMB5L3MBTL1LMNAKDM4EGAA
SCHEMBL26415510 0.87 L3MBTL1 (0.33) PSMB5L3MBTL1LMNAKDM4EGAA
SCHEMBL26416719 0.85 L3MBTL1 (0.36) L3MBTL1LMNAKDM4EGAATDP1
SCHEMBL23385483 0.85 L3MBTL1 (0.40) PSMB5L3MBTL1LMNAKDM4EGAA
SCHEMBL26415617 0.85 KDM4E (0.32) KDM4EMEN1KMT2AHCRTR1ALDH1A1
SCHEMBL27274451 0.84 ESR1 (0.35) HCRTR1ALDH1A1HSD17B1HSD17B2CASP3
SCHEMBL26415503 0.84 L3MBTL1 (0.33) PSMB5L3MBTL1LMNAKDM4EGAA
SCHEMBL26778825 0.83 ALDH1A1 (0.34) L3MBTL1KDM4ETDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 PSMB5 1338/4885L3MBTL1 2788/4885LMNA 2349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.